| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ceabb2ec048d4663d598ad4da154b15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0f6a1c70ddda595eb895b216138591f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_009ec288c961ce7927e07edfe81ca98c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a339683e13a801fb88a3e76ac5b97c46 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
1999-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efbec305cf042beae8ab18962b080705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dfc5fa9d2dc820b4671ebafef415530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4143fab34eadd5056dad097f953608ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6042454981d02f1730fe1c3f5bb2dbc6 |
| publicationDate |
2001-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0018378-A9 |
| titleOfInvention |
Sustained release hydromorphone formulations exhibiting bimodal characteristics |
| abstract |
The invention is related to a biphasic solid sustained release once-a-day oral dosage form comprising hydromorphone or a pharmaceutically acceptable salt thereof together with a sustained release carrier, and to the use thereof in the treatment of human patients. The dosage provides a rise in plasma concentration to an initial early peak concentration, followed by a second peak with plateau plasma concentrations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889740-B1 |
| priorityDate |
1998-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |